Does in vitro fertilization (IVF) treatment provide good value for money? A cost-benefit analysis.

ABSTRACT:

Background

Using traditional health technology assessment (HTA) outcome metrics, such as quality-adjusted life-years, to assess fertility treatments raises considerable methodological challenges because the objective of fertility treatments is to create new life rather than extend, save, or improve health-related quality of life.

Objective

The aim of this study was to develop a novel cost-benefit framework to assess value for money of publicly funded IVF treatment; to determine the number of cost-beneficial treatment cycles for women of different ages; and to perform an incremental cost-benefit analysis from a taxpayer perspective.

Methods

We developed a Markov model to determine the net monetary benefit (NMB) of IVF treatment by female age and number of cycles perfor

SUBMITTER: Keller E 

PROVIDER: S-EPMC10014591 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature